Folate Decorated Multifunctional Biodegradable Nanoparticles for Gastric Carcinoma Active Targeting Theranostics

References

• Hoshi H. Management of gastric adenocarcinoma for general surgeons. Surg Clin North Am. 2020;100(3):523–534. doi:10.1016/j.suc.2020.02.004
   PubMed Web of Science ®Google Scholar
• Li Q, Xu X, Su D, Zhou T, Wang G, Li Z. Long-term survival of an elderly patient with advanced gastric cancer after combination therapy: a case report and literature review. BMC Cancer. 2019;19(1):459. doi:10.1186/s12885-019-5683-4
   PubMed Web of Science ®Google Scholar
• Davern M, Lysaght J. Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers. Cancer Lett. 2020;495:89–99. doi:10.1016/j.canlet.2020.09.014
   PubMed Web of Science ®Google Scholar
• Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, Phase 2/3 trial. Lancet. 2019;393(10184):1948–1957. doi:10.1016/S0140-6736(18)32557-1
   PubMed Web of Science ®Google Scholar
• Iyer R, Croucher JL, Chorny M, et al. Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma. Cancer Lett. 2015;360(2):205–212. doi:10.1016/j.canlet.2015.02.011
   PubMed Web of Science ®Google Scholar
• Sharkey RM, McBride WJ, Cardillo TM, et al. Enhanced delivery of SN-38 to human tumor xenografts with an anti-trop-2-SN-38 antibody conjugate (Sacituzumab Govitecan). Clin Cancer Res. 2015;21(22):5131–5138. doi:10.1158/1078-0432.CCR-15-0670
   PubMed Web of Science ®Google Scholar
• Kawato Y, Aonuma M, Hirota Y, Kuga H, Sato K. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res. 1991;51(16):4187–4191.
   PubMed Web of Science ®Google Scholar
• Huang Q, Wang L, Lu W. Evolution in medicinal chemistry of E-ring-modified Camptothecin analogs as anticancer agents. Eur J Med Chem. 2013;63:746–757. doi:10.1016/j.ejmech.2013.01.058
   PubMed Web of Science ®Google Scholar
• Roger E, Lagarce F, Benoit JP. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration. Eur J Pharm Biopharm. 2011;79(1):181–188. doi:10.1016/j.ejpb.2011.01.021
   PubMed Web of Science ®Google Scholar
• Yang Z, Luo H, Cao Z, et al. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer. Nanoscale. 2016;8(22):11543–11558. doi:10.1039/C6NR01749E
   PubMed Web of Science ®Google Scholar
• Palakurthi S. Challenges in SN38 drug delivery: current success and future directions. Expert Opin Drug Deliv. 2015;12(12):1911–1921. doi:10.1517/17425247.2015.1070142
   PubMed Web of Science ®Google Scholar
• Fang YP, Chuang CH, Wu YJ, Lin HC, Lu YC. SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study. Int J Nanomedicine. 2018;13:2789–2802. doi:10.2147/IJN.S158426
   PubMed Web of Science ®Google Scholar
• Indoria S, Singh V, Hsieh MF. Recent advances in theranostic polymeric nanoparticles for cancer treatment: a review. Int J Pharm. 2020;582:119314. doi:10.1016/j.ijpharm.2020.119314
   PubMed Web of Science ®Google Scholar
• Sah H, Thoma D, Desu S, Sah W, Wood T. Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int J Nanomedicine. 2013;8:747–765. doi:10.2147/IJN.S40579
   PubMed Web of Science ®Google Scholar
• Luo D, Carter KA, Razi A, et al. Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. Biomaterials. 2016;75:193–202. doi:10.1016/j.biomaterials.2015.10.027
   PubMed Web of Science ®Google Scholar
• Sadegh Malvajerd S, Azadi A, Izadi Z, et al. Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: preparation, optimization, and pharmacokinetic evaluation. ACS Chem Neurosci. 2019;10(1):728–739. doi:10.1021/acschemneuro.8b00510
   PubMed Web of Science ®Google Scholar
• Hoshyar N, Gray S, Han H, Bao G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine. 2016;11(6):673–692. doi:10.2217/nnm.16.5
   PubMed Web of Science ®Google Scholar
• Turk MJ, Waters DJ, Low PS. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Lett. 2004;213(2):165–172. doi:10.1016/j.canlet.2003.12.028
   PubMed Web of Science ®Google Scholar
• Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem. 2005;338(2):284–293. doi:10.1016/j.ab.2004.12.026
   PubMed Web of Science ®Google Scholar
• Zwicke GL, Mansoori GA, Jeffery CJ. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Rev. 2012;3(1):18496. doi:10.3402/nano.v3i0.18496
   PubMedGoogle Scholar
• Handali S, Moghimipour E, Kouchak M, et al. New folate receptor targeted nano liposomes for delivery of 5-fluorouracil to cancer cells: strong implication for enhanced potency and safety. Life Sci. 2019;227:39–50. doi:10.1016/j.lfs.2019.04.030
   PubMed Web of Science ®Google Scholar
• Marko AJ, Borah BM, Siters KE, et al. Targeted nanoparticles for fluorescence imaging of folate receptor positive tumors. Biomolecules. 2020;10(12):1651. doi:10.3390/biom10121651
   PubMed Web of Science ®Google Scholar
• Zhang DY, Zheng Y, Zhang H, et al. Folate receptor-targeted theranostic IrS(x) nanoparticles for multimodal imaging-guided combined chemo-photothermal therapy. Nanoscale. 2018;10(47):22252–22262. doi:10.1039/C8NR08095J
   PubMed Web of Science ®Google Scholar
• Farran B, Montenegro RC, Kasa P, et al. Folate-conjugated nanovehicles: strategies for cancer therapy. Mater Sci Eng C Mater Biol Appl. 2020;107:110341. doi:10.1016/j.msec.2019.110341
   PubMed Web of Science ®Google Scholar
• Werner ME, Copp JA, Karve S, et al. Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy. ACS Nano. 2011;5(11):8990–8998. doi:10.1021/nn203165z
   PubMed Web of Science ®Google Scholar
• Cao J, Wei Y, Zhang Y, Wang G, Ji X, Zhong Z. Iodine-rich polymersomes enable versatile SPECT/CT imaging and potent radioisotope therapy for tumor in vivo. ACS Appl Mater Interfaces. 2019;11(21):18953–18959. doi:10.1021/acsami.9b04294
   PubMed Web of Science ®Google Scholar
• Rogers W, Thulasi Seetha S, Refaee TAG, et al. Radiomics: from qualitative to quantitative imaging. Br J Radiol. 2020;93(1108):20190948. doi:10.1259/bjr.20190948
   PubMed Web of Science ®Google Scholar
• Pantel AR, Mankoff DA. Molecular imaging to guide systemic cancer therapy: illustrative examples of PET imaging cancer biomarkers. Cancer Lett. 2017;387:25–31. doi:10.1016/j.canlet.2016.05.008
   PubMed Web of Science ®Google Scholar
• Sirianni RW, Zheng MQ, Patel TR, et al. Radiolabeling of Poly(lactic- co -glycolic acid) (PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomography. Bioconjug Chem. 2014;25(12):2157–2165. doi:10.1021/bc500315j
   PubMed Web of Science ®Google Scholar
• Barani M, Bilal M, Sabir F, Rahdar A, Kyzas GZ. Nanotechnology in ovarian cancer: diagnosis and treatment. Life Sci. 2021;266:118914. doi:10.1016/j.lfs.2020.118914
   PubMed Web of Science ®Google Scholar
• Vasiliu S, Racovita S, Gugoasa IA, Lungan MA, Popa M, Desbrieres J. The benefits of smart nanoparticles in dental applications. Int J Mol Sci. 2021;22(5):2585. doi:10.3390/ijms22052585
   PubMed Web of Science ®Google Scholar
• Jin Y, Wu Z, Li C, et al. Optimization of weight ratio for DSPE-PEG/TPGS hybrid micelles to improve drug retention and tumor penetration. Pharm Res. 2018;35(1):13. doi:10.1007/s11095-017-2340-y
   PubMed Web of Science ®Google Scholar
• Zhu Z, Wu M, Sun J, et al. Redox-sensitive iodinated polymersomes carrying histone deacetylase inhibitor as a dual-functional nano-radiosensitizer for enhanced radiotherapy of breast cancer. Drug Deliv. 2021;28(1):2301–2309. doi:10.1080/10717544.2021.1995080
   PubMed Web of Science ®Google Scholar
• Cardiff RD, Miller CH, Munn RJ. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc. 2014;2014(6):655–658. doi:10.1101/pdb.prot073411
   PubMedGoogle Scholar
• Loo DT. In situ detection of apoptosis by the TUNEL assay: an overview of techniques. Methods Mol Biol. 2011;682:3–13.
   PubMedGoogle Scholar
• Safa AR. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil. Proc Natl Acad Sci USA. 1988;85(19):7187–7191. doi:10.1073/pnas.85.19.7187
   PubMed Web of Science ®Google Scholar
• Gupta E, Safa AR, Wang X, Ratain MJ. Pharmacokinetic modulation of irinotecan and metabolites by cyclosporin A. Cancer Res. 1996;56(6):1309–1314.
   PubMed Web of Science ®Google Scholar
• Yang X, Xue X, Luo Y, et al. Sub-100nm, long tumor retention SN-38-loaded photonic micelles for tri-modal cancer therapy. J Control Release. 2017;261:297–306. doi:10.1016/j.jconrel.2017.07.014
   PubMed Web of Science ®Google Scholar
• Wang DF, Rong WT, Lu Y, et al. TPGS 2k /PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells. ACS Appl Mater Interfaces. 2015;7(7):3888–3901. doi:10.1021/am508340m
   PubMed Web of Science ®Google Scholar
• Muniswamy VJ, Raval N, Gondaliya P, Tambe V, Kalia K, Tekade RK. “Dendrimer-Cationized-Albumin” encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin. Int J Pharm. 2019;555:77–99. doi:10.1016/j.ijpharm.2018.11.035
   PubMed Web of Science ®Google Scholar
• Kim M, Pyo S, Kang CH, et al. Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer. PLoS One. 2018;13(6):e0198347. doi:10.1371/journal.pone.0198347
   PubMed Web of Science ®Google Scholar
• Shen X, Li T, Chen Z, et al. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics. Int J Nanomedicine. 2017;12:4299–4322. doi:10.2147/ijn.s136766
   PubMed Web of Science ®Google Scholar
• Operti MC, Bernhardt A, Grimm S, Engel A, Figdor CG, Tagit O. PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up. Int J Pharm. 2021;605:120807. doi:10.1016/j.ijpharm.2021.120807
   PubMed Web of Science ®Google Scholar
• Liu X, Wang J, Huang YW. Quantifying the effect of nano-TiO(2) on the toxicity of lead on C. dubia using a two-compartment modeling approach. Chemosphere. 2021;263:127958. doi:10.1016/j.chemosphere.2020.127958
   PubMed Web of Science ®Google Scholar
• Fang T, Zhu W, Li C, et al. Role of surface RGD patterns on protein nanocages in tumor targeting revealed using precise discrete models. Small. 2019;15(51):e1904838. doi:10.1002/smll.201904838
   PubMed Web of Science ®Google Scholar
• Atsumi R, Okazaki O, Hakusui H. Pharmacokinetics of SN-38 [(+)-(4S)-4,11-diethyl-4,9-dihydroxy-1H- pyrano[3’,4’:6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione], an active metabolite of irinotecan, after a single intravenous dosing of 14C-SN-38 to rats. Biol Pharm Bull. 1995;18(8):1114–1119. doi:10.1248/bpb.18.1114
   PubMed Web of Science ®Google Scholar
• Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK. Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C Mater Biol Appl. 2019;98:1252–1276. doi:10.1016/j.msec.2019.01.066
   PubMed Web of Science ®Google Scholar
• Peng F, Setyawati MI, Tee JK, et al. Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness. Nat Nanotechnol. 2019;14(3):279–286. doi:10.1038/s41565-018-0356-z
   PubMed Web of Science ®Google Scholar